Gainutdinov 2022 BEC: Difference between revisions
Tindle Lisa (talk | contribs) (Created page with "{{BEC}} right|290px|Bioenergetics Communications|link=https://www.bioenergetics-communications.org/index.php/bec/index {{Publication |title=Gainutdin...") |
Tindle Lisa (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{Publication | {{Publication | ||
|title=Gainutdinov T, Debska-Vielhaber G, Gizatullina Z, Vielhaber S, Orynbayeva Z, Gellerich FN (2022) Impaired Ca<sup>2+</sup> signaling indicates disturbed mitochondrial function in fibroblasts from patients with sporadic and familial ALS. Bioenerg Commun 2022.18. https://doi.org/10.26124/bec:2022-0018 | |title=Gainutdinov T, Debska-Vielhaber G, Gizatullina Z, Vielhaber S, Orynbayeva Z, Gellerich FN (2022) Impaired Ca<sup>2+</sup> signaling indicates disturbed mitochondrial function in fibroblasts from patients with sporadic and familial ALS. Bioenerg Commun 2022.18. https://doi.org/10.26124/bec:2022-0018 | ||
|info=Bioenerg Commun 2022.18. [[File:OpenAccess-downloadPDF.png|200px||link= |Open Access pdf]]<br /> ''published online'' 2022-12-09 | |info=Bioenerg Commun 2022.18. [[File:OpenAccess-downloadPDF.png|200px||link=https://www.bioenergetics-communications.org/index.php/bec/article/view/gainutdinov_2022/153 |Open Access pdf]]<br /> ''published online'' 2022-12-09 | ||
<br /><br /> | <br /><br /> | ||
|authors=AGainutdinov Timur, Debska-Vielhaber Grazyna, Gizatullina Zemfira, Vielhaber Stefan, Orynbayeva Zulfiya, Gellerich Frank Norbert | |authors=AGainutdinov Timur, Debska-Vielhaber Grazyna, Gizatullina Zemfira, Vielhaber Stefan, Orynbayeva Zulfiya, Gellerich Frank Norbert | ||
Revision as of 18:13, 9 December 2022
| Gainutdinov T, Debska-Vielhaber G, Gizatullina Z, Vielhaber S, Orynbayeva Z, Gellerich FN (2022) Impaired Ca2+ signaling indicates disturbed mitochondrial function in fibroblasts from patients with sporadic and familial ALS. Bioenerg Commun 2022.18. https://doi.org/10.26124/bec:2022-0018 |
» Bioenerg Commun 2022.18. 
published online 2022-12-09
AGainutdinov Timur, Debska-Vielhaber Grazyna, Gizatullina Zemfira, Vielhaber Stefan, Orynbayeva Zulfiya, Gellerich Frank Norbert (BEC 2022.18) Bioenerg Commun
Abstract: 
https://doi.org/10.26124/bec:2022-0018
Amyotrophic lateral sclerosis (ALS) is a progressive, devastating, neurodegenerative disorder affecting upper and lower motor neurons. Common mechanisms of ALS pathogenesis disturb cellular calcium homeostasis and cause mitochondrial dysfunction. Both influence mutually each other. As a result, chronic mitochondrial energy stress impairs cellular signaling and transport processes, leading to degeneration of motor neurons. We measured cytosolic Ca2+ in healthy and ALS fibroblasts. Mitochondrial calcium retention capacity in fibroblasts obtained from patients with sporadic (sALS) and familial (fALS) ALS differed between two subtypes and from healthy individuals. Changes of [Ca2+]cyt dynamics in ALS fibroblasts was partially rescued by treatment with antioxidants (Trolox and CoQ10). These results confirm a causative role of oxidative stress in mitochondrial dysfunction linked to ALS.
• Keywords: ALS, CoQ10, cellular Ca2+ homeostasis, histamine, mitochondria, Trolox
• Bioblast editor: Tindle-Solomon L
• O2k-Network Lab: DE Bonn Kunz WS, DE Magdeburg Debska-Vielhaber G, DE Magdeburg Gellerich FN
ORCID: 
Gainutdinov Timur, Debska-Vielhaber Grazyna, Gizatullina Zemfira, Vielhaber Stefan, Orynbayeva Zulfiya, Gellerich Frank Norbert
MitoFit Preprint
Labels: MiParea: Patients
Pathology: Inherited, Neurodegenerative
Organism: Human Tissue;cell: Fibroblast Preparation: Intact cells
Regulation: Calcium
BEC
